Efficacy of Lapaquistat Co-Administered With Statins in Subjects With Hypercholesterolemia

This study has been terminated.

( Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents )

Study NCT00532311 Information provided by Takeda Global Research & Development Center, Inc.

First Received: September 18, 2007 Last Updated: January 14, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	April 2008
Primary Completion Date:	April 2008 (Final data collection date for primary outcome measure)